New research: Ex-footballers more likely to get Parkinson's
Former professional footballers are more likely to die with a neurodegenerative condition such as dementia or Parkinson's than the general population, according to new research.
MPs show their support for our Get It On Time campaign
Update on our visit to Parliament to promote our latest report to improve medication management for people with Parkinson's in hospital
Cannabis and Parkinson's
Earlier this year, we surveyed 1,600 people with Parkinson's and 29 health professionals about using cannabis-derived products. Here are the results.
Can cannabis stop Parkinson's hallucinations?
A pioneering clinical trial will investigate if cannabidiol (CBD) – a compound found in the cannabis plant – can treat hallucinations and delusions in people living with Parkinson’s.
World mental health day - tips to manage your mental health
We're making World Mental Health Day by sharing some tips on managing your mental health from a person with Parkinson's and a Parkinson's nurse
Promising results from a phase II study for people with early-stage Parkinson’s
A phase II clinical trial of tavapadon, a drug developed by Cerevel Therapeutics, has shown improvements in movement symptoms. The results have been announced on the company website.
Ten member group appointed to strengthen Parkinson’s UK Scotland
Parkinson’s UK Scotland is delighted that it has been able to appoint ten outstanding candidates to a new advisory group that will be at the heart of shaping the charity’s work in Scotland.
Sign our petition to help people with Parkinson’s in hospital get their medication on time
Information about our latest campaign to improve care for people with Parkinson's in hospital and a request for people to sign our petition
How you’ve shaped our new strategy
Together, we’ve been working on our 2020 to 2024 strategy. Scaling up our previous successes, it’s more ambitious than ever. Because you’ve told us it has to be.
New guide to help charities and patients work with drug companies
A new guide has been launched to help charities support patients to have their say on research carried out by the pharmaceutical industry.